NCT00966355View on ClinicalTrials.gov

Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

1,034

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Variceal Bleeding, Cirrhosis
Interventions
DRUG

Terlipressin

loading with 2 mg IV, and then 1 mg IV every 4 hours for 5 days

DRUG

Somatostatin

loading with 250 microgram IV, and then 250 microgram/hour continuous IV for 5 days

DRUG

Octreotide

loading with 50 microgram IV, and then 25 microgram/hour continuous IV for 5 days

Trial Locations (1)

136-705

Korea University Anam Hospital, Seoul

All Listed Sponsors
lead

Korea University

OTHER

NCT00966355 - Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding | Biotech Hunter | Biotech Hunter